Skip to main content
Richard Schulick, MD, General Surgery, Aurora, CO

Richard David Schulick MD MBA

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)


Professor and Chair of Surgery, University Colorado School of Medicine Director of the University of Colorado Cancer Center

Join to view full profile
  • 12631 E 17th St, Rm 6117, MSC305University of Colorado School of MedicineAurora, CO 80045

  • Phone+1 303-720-2752

  • Fax+1 303-724-2761

Dr. Schulick is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityMBA, Business of Medicine, 2010
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1997 - 1999
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Advanced GI Minimally Invasive Surgery, 1996 - 1997
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Surgery, 1989 - 1996
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Clinical Pharmacology, 1991 - 1993

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2028
  • CO State Medical License
    CO State Medical License 2012 - 2027
  • MD State Medical License
    MD State Medical License 1992 - 2025
  • Surgery
    American Board of Surgery Surgery
  • American Board of Clinical Pharmacology
    American Board of Clinical PharmacologyAmerican Board of Clinical Pharmacology
  • Complex Surgical Oncology
    Society of Surgical OncologyComplex Surgical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly
  • America's Top Doctors for Cancer Castle Connolly
  • Fellow American Board of Clinical Pharmacology American Board of Clinical Pharmacology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Commentary on optimizing choledocholithiasis management: A cost effectiveness analysis  
    Schulick RD, Arch Surg, 1/1/2007
  • A guide to adrenocortical carcinoma management  
    Schulick RD, Hosp Pharm Eur, 1/1/2003
  • The Use of Pancreatic Enzymes after Pancreatic Surgery  
    Schulick RD, Proceedings of a Faculty Symposium on the Use of Pancreatic Enzymes, 1/1/2003

Books/Book Chapters

Lectures

  • Liver Lesions in My Patient-Should I Observe, Further Test, or Treat 
    Wheat Ridge, CO - 1/24/2016
  • Management of Hilar Cholangiocarcinoma in 2016 
    Buffalo, NY - 1/23/2016
  • The Future of Cancer Treatments 
    Aurora, CO - 1/21/2016

Other

  • Pancreaticoduodenectomy with Reconstruction (Video) 
    Schulick RD, Turkish Hepatopancreatobiliary Surgical Congress
    Antalya, Turkey - 1/9/2011
  • Surgical Management of Hepatic Colorectal Cancer Metastases-Potential Role of Vaccines 
    Schulick RD, Video Teleconference, Hospital Punta Pacifica
    Panama City, Panama - 1/3/2006
  • Commentary on the safety and efficacy of laparoscopic adrenalectomy in children. 
    Schulick RD
    1/1/2005

Authored Content

  • Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?March 2018

Press Mentions

  • Anonymous Alum Donation Helps CU Surgery Residents Attend Southwestern Surgical Congress Annual Meeting
    Anonymous Alum Donation Helps CU Surgery Residents Attend Southwestern Surgical Congress Annual MeetingMay 21st, 2026
  • When Stage 4 Colon Cancer Spread to Her Liver, Peggy Was Given Months to Live. That Was 13 Years Ago
    When Stage 4 Colon Cancer Spread to Her Liver, Peggy Was Given Months to Live. That Was 13 Years AgoMarch 30th, 2026
  • ‘You’re Not the Only One Going Through This’: A Head & Neck Cancer Survivor Supports Others and Advises the CU Cancer Center
    ‘You’re Not the Only One Going Through This’: A Head & Neck Cancer Survivor Supports Others and Advises the CU Cancer CenterDecember 17th, 2025

Grant Support

  • UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal CancerUNIVERSITY OF COLORADO DENVER2025–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: